Dec. 18 /PRNewswire/ -- MDS Proteomics Inc., a company focused on functional proteomics, and Zyomyx, Inc, a developer of protein biochip technologies, today announced they plan to work together to enhance cell research through protein pathway identification and analysis.
Zyomyx and MDS Proteomics have entered into an agreement that will draw on Zyomyx' protein biochip technology and MDS Proteomics' protein pathway identification and analysis expertise to collaborate exclusively on research to prove the use of protein biochips in mass spectrometry-based proteomic studies. The protein biochip technology developed by Zyomyx utilizes advanced materials science techniques to create high-density arrays of fully functional proteins captured on biochips. The platform will be the first to permit the highly parallel measurement of protein abundance, structure and activity and will be a novel tool in identifying and analyzing protein pathways.
MDS Proteomics has also purchased an equity stake in Zyomyx for $2.5 million as part of Zyomyx' recently completed Series-D financing. Additionally, MDS Proteomics will provide funding to Zyomyx to support research and development efforts.
``It is not enough to identify proteins; rather, we must understand how they act and interact with each other,'' said MDS Proteomics President and Chief Executive Officer Frank Gleeson. ``This alliance is part of our effort to build a platform to identify key protein pathways, which will allow us to better understand the role proteins play in disease. We expect this combination of technologies and expertise to broaden the technological base from which we and our partners hope to ultimately develop new therapeutics and diagnostic products.''
``The emerging field of proteomics has created new challenges as well as new avenues for invention and discovery,'' said Zyomyx Chief Executive Officer Yasunori Kaneko, M.D. ``The goal of the collaboration is to merge Zyomyx' protein biochip capabilities with the protein analysis expertise of MDS Proteomics to develop novel and useful tools to advance the understanding of how proteins interact with one another in the cell. We believe this understanding will play a critical role in the development of new therapeutics.'.... |
